• OPEN AN ACCOUNT
Indian Indices
Sensex
83,739.13 2,072.67
( 2.54%)
Global Indices
Nasdaq
49,433.27 519.79
(1.06%)
Dow Jones
6,997.90 37.87
(0.54%)
Hang Seng
54,706.11 2,050.93
(3.90%)
Nikkei 225
10,322.91 99.37
(0.97%)
Forex
USD-INR
91.61 -0.04
(-0.05%)
EUR-INR
108.55 -0.05
(-0.05%)
GBP-INR
125.35 -0.06
(-0.05%)
JPY-INR
0.59 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
411.5552288
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
23.13
105960.63
EPS(TTM)
Face Value()
Div & Yield %
56.72
2
1.22
 

Kolte-Patil Developers inks deal to jointly develop land parcel in Pune
Jan 14,2026

Bhugaon, is an emerging residential destination in Pune, blending natural flora and fauna with excellent urban connectivity.

This land parcel is surrounded by established premium markets like Bavdhan and Kothrud and is adjacent to the Mumbai-Pune Expressway as well as Shivaji Nagar railway station.

The project is set to benefit from being in close proximity to large employment hubs as well as the access to advanced social infrastructure comprising schools, hospitals, shopping malls and entertainment hubs making this a very unique and attractive proposition.

Rajesh Patil, managing director, Kolte-Patil Developers, said: “This transaction aligns with our strategy to systematically strengthen our presence in high-potential micro-markets benefitting from evolving demand trends.

This project in Bhugaon marks the next step in expanding our portfolio through capital-efficient partnerships.'

The Kolte-Patil Developers group is one of the largest residential real estate developers in Pune. The company has a healthy project portfolio of affordable, mid-income, and luxury residential segments through its brands, Kolte-Patil and 24K, respectively, and is expanding its presence in Bengaluru and Mumbai.

The company had recorded a consolidated net loss of Rs 10.43 crore in the quarter ended September 2025 as against net profit of Rs 9.74 crore during the previous quarter ended September 2024. Sales declined 55.02% to Rs 138.66 crore in Q2 FY26 over Q2 FY25.

The scrip shed 0.74% to currently trade at Rs 368.60 on the BSE.